ATE454451T1 - Methode zur behandlung von muskelkrankheiten - Google Patents

Methode zur behandlung von muskelkrankheiten

Info

Publication number
ATE454451T1
ATE454451T1 AT06003275T AT06003275T ATE454451T1 AT E454451 T1 ATE454451 T1 AT E454451T1 AT 06003275 T AT06003275 T AT 06003275T AT 06003275 T AT06003275 T AT 06003275T AT E454451 T1 ATE454451 T1 AT E454451T1
Authority
AT
Austria
Prior art keywords
muscle diseases
treating muscle
treating
diseases
igf
Prior art date
Application number
AT06003275T
Other languages
English (en)
Inventor
Geoffrey Goldspink
Shi Yu Yang
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE454451T1 publication Critical patent/ATE454451T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06003275T 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten ATE454451T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605124.8A GB9605124D0 (en) 1996-03-11 1996-03-11 Method of treating muscular disorders

Publications (1)

Publication Number Publication Date
ATE454451T1 true ATE454451T1 (de) 2010-01-15

Family

ID=10790201

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06003275T ATE454451T1 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten
AT97906296T ATE326534T1 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97906296T ATE326534T1 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten

Country Status (10)

Country Link
US (1) US6221842B1 (de)
EP (2) EP1726651B1 (de)
JP (1) JP2000506729A (de)
AT (2) ATE454451T1 (de)
DE (2) DE69735883T2 (de)
DK (2) DK1726651T3 (de)
ES (2) ES2337917T3 (de)
GB (1) GB9605124D0 (de)
PT (2) PT894136E (de)
WO (1) WO1997033997A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2190369A1 (en) * 1994-05-16 1995-11-23 Vitold Raimond Kruka Process for upgrading residual hydrocarbon oils
US7700353B2 (en) * 1998-07-22 2010-04-20 E-P Therapeutics, Inc. Compositions and methods for inducing apoptosis in tumor cells
US7118752B2 (en) * 1998-07-22 2006-10-10 University Of Connecticut Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I
GB9926968D0 (en) * 1999-11-15 2000-01-12 Univ London Treatment of neurological disorders
GB0011278D0 (en) * 2000-05-10 2000-06-28 Univ London Repair of nerve damage
US7326417B2 (en) 2001-09-11 2008-02-05 Merial Ltd. IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
FR2829498B1 (fr) * 2001-09-11 2003-11-28 Merial Sas Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
GB0202906D0 (en) * 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
US20050125914A1 (en) * 2003-11-18 2005-06-16 Gerard Malle Hair shaping composition comprising at least one- non-hydroxide base
JP2008533114A (ja) * 2005-03-18 2008-08-21 ユーシーエル ビジネス パブリック リミテッド カンパニー メカノ成長因子ペプチドおよびその使用
US20090221072A1 (en) * 2006-02-15 2009-09-03 Chen Thomas T Compositions and methods for modulating cell differentiation
CL2007001614A1 (es) 2006-06-09 2008-08-08 Novartis Ag Polipeptido que comprende una proteina del precursor del factor de crecimiento tipo insulina, igf-1 humana, en la cual la escision del peptido e mediante una proteasa se reduce a traves de la modificacion de la proteina del precursor; y su uso para t
CN101466398A (zh) * 2006-06-09 2009-06-24 诺瓦提斯公司 稳定的胰岛素样生长因子多肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
SE9100099D0 (sv) 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
WO1995013290A1 (en) * 1993-11-12 1995-05-18 North Shore University Hospital Research Corporation Method of treating muscular dystrophy

Also Published As

Publication number Publication date
WO1997033997A1 (en) 1997-09-18
EP0894136A1 (de) 1999-02-03
PT1726651E (pt) 2010-04-08
DK0894136T3 (da) 2006-09-18
DK1726651T3 (da) 2010-04-12
EP1726651B1 (de) 2010-01-06
EP1726651A1 (de) 2006-11-29
DE69735883T2 (de) 2007-04-19
DE69739737D1 (de) 2010-02-25
GB9605124D0 (en) 1996-05-08
US6221842B1 (en) 2001-04-24
PT894136E (pt) 2006-10-31
DE69735883D1 (de) 2006-06-22
EP0894136B1 (de) 2006-05-17
ES2337917T3 (es) 2010-04-30
JP2000506729A (ja) 2000-06-06
ES2265649T3 (es) 2007-02-16
ATE326534T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
ATE326534T1 (de) Methode zur behandlung von muskelkrankheiten
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE59610964D1 (de) Anordnung zur elektro-thermischen Behandlung des menschlichen oder tierischen Körpers
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE3888273D1 (de) Medizinischer Apparat zur Behandlung mit Ultraschall.
ATE247504T1 (de) Vorrichtung zur behandlung des menschlichen körpers durch endermatische elektrotherapie
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
DE69129267D1 (de) Methode zur behandlung intestinaler krankheiten
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
ATE335759T1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
EP0967276A3 (de) Antitumor-Mittel dass Salmosin enthält
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
EP1143996A4 (de) Methode zur behandlung von chronischen herzerkrankungen
DE3865283D1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE319472T1 (de) Verfahren zur behandlung der gefässerkrankungen mit aktiviertem protein c
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
DE69830811D1 (de) Verwendung von Oxazolidinonderivaten zur Behandlung von Psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1726651

Country of ref document: EP